Characteristics of intestinal absorption and disposition of glycyrrhizin in mice

Biopharmaceutics and Drug Disposition

Volumn 21, Issue 3, 2000, Pages 95-101

  Shibata, Nobuhito ^a   Shimokawa, Tatsuharu ^a   Jiang, Zhi Qiang ^a   Jeong, Young Il ^a   Ohno, Tomoya ^a   Kimura, Go ^a   Yoshikawa, Yukako ^a   Koga, Kenji ^b   Murakami, Masahiro ^a   Takada, Kanji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

Author keywords

Glycyrrhetic acid; Glycyrrhizin; Intestinal absorption; Oral bioavailability; PCDCS

Indexed keywords

GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG EFFICACY; DRUG HALF LIFE; DRUG TISSUE LEVEL; IN VIVO STUDY; INTESTINE ABSORPTION; MALE; MOUSE; NONHUMAN; PRESSURE;

ANIMALS; AREA UNDER CURVE; GLYCYRRHIZIC ACID; INTESTINAL ABSORPTION; LIVER; MALE; MICE; STEREOISOMERISM;

EID: 0033659695     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-081X(200004)21:3<95::AID-BDD221>3.0.CO;2-9     Document Type: Article

References (18)

1. Review article: Glycyrrhizin as a potential treatment for chronic hepatitis C
2. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice
3. Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antivial activities
4. Comparative studies of the inhibitory properties of antibiotics on human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases and cellular DNA polymerases
5. Gastrointestinal absorption characteristics of glycyrrhizin from glycyrrhiza extract
6. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method
7. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats: Relevance to the intestinal bacterial hydrolysis
8. Biotransformation of glycyrrhizin to 18β-glycyrrhetinic acid-3-O-β-D-glucose by streptococcus LJ-22, a human intestinal bacteria
9. Mechanism of gastrointestinal absorption of glycyrrhizin in rats
10. Technology to obtain sustained release characteristics of drugs after delivered to the colon
11. A dissolution test for a pressure-controlled colon delivery capsule: Rotating beads method
12. New preparation method of intestinal pressure-controlled colon delivery capsules by coating machine and evaluation in beagle dogs
13. Importance of dissolution process on systemic availability of drugs delivered by colon delivery system
14. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers
15. Determination of 18α-glycyrrhizin and 18β-glycyrrhizin in dog plasma by high-performance liquid chromatography
16. Development and evaluation of noncompartmental pharmacokinetic analysis program 'WinHARMONY' using visual BASIC language having a function of an automatic recognition of terminal elimination phase of plasma drug concentration vs. time profile
17. Determination of urinary 18β-glycyrrhetinic acid by gas chromatography and its clinical application in man
18. Colonic drug targeting